In addition, high levels of TBK1 expression were correlated with poorer prognosis of OS in BRCA, ESCA, kidney chromophobe (KICH), KIRP, brain lower grade glioma (LGG), LUAD, Ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD), and uveal melanoma (UVM). Here, TBK1 is linked to chromophobe renal cell carcinoma.